Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.

IF 6.5 1区 医学 Q1 IMMUNOLOGY NPJ Vaccines Pub Date : 2024-11-27 DOI:10.1038/s41541-024-01030-8
Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert
{"title":"Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.","authors":"Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert","doi":"10.1038/s41541-024-01030-8","DOIUrl":null,"url":null,"abstract":"<p><p>Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"9 1","pages":"237"},"PeriodicalIF":6.5000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603308/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-024-01030-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
狗咬伤病例暴露后狂犬病预防后一年免疫力评估。
尽管暴露后预防(PEP)可以预防狂犬病,但狂犬病仍然是全球健康的威胁。本研究评估了接受世界卫生组织推荐的柬埔寨巴斯德研究所(IPC)方案的 PEP 受试者一年的体液免疫和 T 细胞免疫情况。我们分析了狂犬病病毒 (RABV) 中和抗体 (nAbs) 和 T 细胞在 PEP 后基线、7 天和 14 天、6 个月和 12 个月的反应。我们共纳入了 148 名患者,其中 78 人被确诊为 RABV 阳性的狗咬伤,接受了 PEP 和马狂犬病免疫球蛋白 (eRIG),70 人被 RABV 阴性的狗咬伤,只接受了 PEP。PEP 14 天后,除两人外,其他所有人都出现了 nAbs 血清转换(≥ 0.5 IU/mL),其中 87% 的人在 12 个月后仍能保持这种反应。分泌白细胞介素-4(IL-4)和γ干扰素(IFN-γ)的 T 细胞在 14 天后显著升高,并持续一年。在接触过 RABV 和未接触过 RABV 的组别之间未观察到差异。这项研究证明了 IPC PEP 一年后的强大免疫力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
NPJ Vaccines
NPJ Vaccines Immunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍: Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.
期刊最新文献
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59. Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus. Evaluation of protective efficacy of an inactivated Japanese encephalitis virus genotype Ⅴ strain in mice. Association between COVID-19 vaccine efficacy and epidemic force of infection. Heterologous immunization modulates B-cell epitope competition between helper peptides and the MPER segment in MPER/liposome vaccines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1